HOME >> MEDICINE >> NEWS
Urgent action required to tackle escalating road-traffic crashes worldwide

A review in this week's issue of THE LANCET highlights how concerted action is urgently needed worldwide to tackle the global burden of injuries and deaths caused by road-traffic crashes. Attention is specifically required in low and middle-income countries where the numbers of road injuries and deaths continues to rise.

Around 1.2 million people were killed and 50 million injured in road-traffic crashes worldwide in 2002, costing the global community about US$518 billion. The International Federation of Red Cross and Red Crescent Societies has described the situation as "a worsening global disaster destroying lives and livelihoods, hampering development and leaving millions in greater vulnerability". Without appropriate action, road-traffic injuries are predicted to escalate from the ninth leading contributor to the global burden of disease in 1990 to the third by 2020.

A 2004 WHO report and the subsequent collaboration of 42 agencies worldwide led to the UN General Assembly to pass a new resolution on road safety on Oct 26, 2005. In addition to recommending the implementation of the WHO report to reduce road-traffic injuries and deaths, the UN also called for the organisation of the first UN Global Road-Safety Week (April 2326, 2007); and requested that Member States and the international community recognise the third Sunday in November of every year as the World Day of Remembrance for Road-Traffic Victims.

Associate Professor Shanthi Ameratunga (University of Auckland, New Zealand) and colleagues outline the current evidence for the severe toll that road-traffic crashes have worldwide, and emphasise the under-reported burden in low and middle-income countries.

Dr Ameratunga comments: "Motorisation has enhanced the lives of many individuals and societies. But the benefits have come with a price. Although the numbers of lives lost in road crashes in high-income countries have declined in recent decades, for most of the world's popu
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
4-May-2006


Page: 1 2

Related medicine news :

1. Urgent need for guidance on mobile phone use in clinical care
2. Child Survival Symposium: Urgent action needed to reduce child mortality worldwide by 2015
3. Urgent changes needed for authorisation of phase I trials
4. Urgent measures needed to tackle HIV epidemic in Moscow
5. Drug interactions with warfarin
6. States taking action to insure nations 13.3M uninsured young adults
7. Paying taxes, according to the brain, can bring satisfaction
8. CAM-oriented primary care providers result in cost savings, high patient satisfaction
9. Panel offers guidelines on skin reactions to new class of cancer drugs
10. Data showed improved quality of life and patient satisfaction with SYMBICORT
11. Chronic pain can drive you to distraction

Post Your Comments:
(Date:2/27/2015)... Mequon, Wisconsin (PRWEB) February 27, 2015 ... facial plastic surgeons , is pleased to announce the ... location now open in Delafield. Quintessa has begun seeing ... Campbell, the new Delafield location will offer a variety ... patients, including: Botox, filler injectables, micro laser peels, chemical ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Legislation ... Committee, includes a pharmacy provision to help prevent ... the pharmacy counter. The Protecting the Integrity of ... Health Subcommittee Chairman Kevin Brady (R-TX) and Ranking ... address the prescription drug abuse epidemic and implement ...
(Date:2/27/2015)... The winter season is here, and with ... mold grows, it can be harmful to the home and ... consequences of mold growth with the help of Enviro-Test. Enviro-Test, ... on the best ways to prevent mold during the winter ... conditions for mold to thrive. Mold must be removed properly, ...
(Date:2/27/2015)... FACE Skincare~Medical~Wellness, a multiaward-winning leader in ... combination to take fifteen years off of an ... new treatment introduced that is the first and ... improve lines and wrinkles on the Décolleté. This ... from the stubborn vertical lines between the upper ...
(Date:2/27/2015)... February 27, 2015 The UC Davis ... expertise have made it a beacon of hope for ... has been acknowledged by the national society committed to ... Huntington’s Disease Society of America — as a Level ... acknowledgement recognizes the center’s service to over 300 families ...
Breaking Medicine News(10 mins):Health News:Dr. Andrew Campbell Expands Quintessa Aesthetic Center into Delafield 2Health News:Dr. Andrew Campbell Expands Quintessa Aesthetic Center into Delafield 3Health News:PCMA Statement on the ‘Protecting the Integrity of Medicare Act’ 2Health News:Enviro-Test Offers Tips for Winter Mold Prevention 2Health News:Face Skincare Announces New Combination Therapy 2Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 2Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 3
(Date:2/27/2015)... 27, 2015  Boston Scientific Corporation (NYSE: ... 2015 Annual Healthcare Conference on March 10 in ... Brennan , executive vice president and chief financial officer, ... will participate in a 25-minute question and answer session ... 1:05 p.m. ET. Following a 5-minute break, a question ...
(Date:2/27/2015)... SOUTH PLAINFIELD, N.J., Feb. 27, 2015  PTC Therapeutics, ... corporate update and reported financial results for the fourth ... "2014 was a transformative year for PTC. ... on delivering and developing RNA-targeted therapies in the rare ... Officer, PTC Therapeutics, Inc. "We are proud to bring ...
(Date:2/27/2015)... and JERUSALEM , Feb. 27, 2015 ... octreotide capsules, its lead product for the orphan condition ... Series E financing round. Participants in the financing included ... an undisclosed blue chip public investment fund, as well ... Health Ventures, Abingworth and ARCH Venture Partners. ...
Breaking Medicine Technology:Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3
Cached News: